Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2015-2024

The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the BRIC pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

– Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the pharmaceuticals industry and had a total market value of $233.0 billion in 2019. Russia was the fastest growing country with a CAGR of 9.9% over the 2015-19 period.

– Within the pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $142.6 billion in 2019. This was followed by India, Brazil and Russia with a value of $32.5, $29.6, and $28.4 billion, respectively.

– China is expected to lead the pharmaceuticals industry in the BRIC nations with a value of $206.3 billion in 2024, followed by India, Brazil, Russia with expected values of $38.6, $35.7 and $35.1 billion, respectively.

Scope

– Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC pharmaceuticals market

– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC pharmaceuticals market

– Leading company profiles reveal details of key pharmaceuticals market players’ BRIC operations and financial performance

– Add weight to presentations and pitches by understanding the future growth prospects of the BRIC pharmaceuticals market with five year forecasts

– Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country

Reasons to buy

- What was the size of the BRIC pharmaceuticals market by value in 2019?

- What will be the size of the BRIC pharmaceuticals market in 2024?

- What factors are affecting the strength of competition in the BRIC pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitors in the BRIC pharmaceuticals market?

Companies mentioned

Ache Laboratorios Farmaceuticos SA

Aurobindo Pharma Ltd

Bayer AG

Dr. Reddy's Laboratories Limited

EMS Sigma Pharma

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Guangzhou Pharmaceuticals Corp

Les Laboratoires Servier

Lupin Ltd

Novartis AG

Sanofi SA

Shanghai Pharmaceutical Co Ltd

Sun Pharmaceutical Industries Inc

Yangtze River Pharmaceutical Group

Table of Contents

Table of Contents

1 Introduction

1.1. What is this report about?

1.2. Who is the target reader?

1.3. How to use this report

1.4. Definitions

2 BRIC Pharmaceuticals

2.1. Industry Outlook

3 Pharmaceuticals in Brazil

3.1. Market Overview

3.2. Market Data

3.3. Market Segmentation

3.4. Market outlook

3.5. Five forces analysis

3.6. Macroeconomic Indicators

4 Pharmaceuticals in China

4.1. Market Overview

4.2. Market Data

4.3. Market Segmentation

4.4. Market outlook

4.5. Five forces analysis

4.6. Macroeconomic Indicators

5 Pharmaceuticals in India

5.1. Market Overview

5.2. Market Data

5.3. Market Segmentation

5.4. Market outlook

5.5. Five forces analysis

5.6. Macroeconomic Indicators

6 Pharmaceuticals in Russia

6.1. Market Overview

6.2. Market Data

6.3. Market Segmentation

6.4. Market outlook

6.5. Five forces analysis

6.6. Macroeconomic Indicators

7 Company Profiles

7.1. Sanofi SA

7.2. EMS Sigma Pharma

7.3. Ache Laboratorios Farmaceuticos SA

7.4. Yangtze River Pharmaceutical Group

7.5. Shanghai Pharmaceutical Co Ltd

7.6. Guangzhou Pharmaceuticals Corp

7.7. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

7.8. Lupin Ltd

7.9. Sun Pharmaceutical Industries Inc

7.10. Dr. Reddy's Laboratories Limited

7.11. Aurobindo Pharma Ltd

7.12. Bayer AG

7.13. Novartis AG

7.14. Les Laboratoires Servier

8 Appendix

8.1. Methodology

8.2. About MarketLine

List of Tables

List of Tables

Table 1: BRIC pharmaceuticals industry, revenue($bn), 2015-24

Table 2: BRIC pharmaceuticals industry, revenue($bn), 2015-19

Table 3: BRIC pharmaceuticals industry, revenue($bn), 2019-24

Table 4: Brazil pharmaceuticals market value: $ billion, 2015-19

Table 5: Brazil pharmaceuticals market geography segmentation: $ billion, 2019

Table 6: Brazil pharmaceuticals market share: % share, by value, 2019

Table 7: Brazil pharmaceuticals market value forecast: $ billion, 2019-24

Table 8: Brazil size of population (million), 2015-19

Table 9: Brazil gdp (constant 2005 prices, $ billion), 2015-19

Table 10: Brazil gdp (current prices, $ billion), 2015-19

Table 11: Brazil inflation, 2015-19

Table 12: Brazil consumer price index (absolute), 2015-19

Table 13: Brazil exchange rate, 2015-19

Table 14: China pharmaceuticals market value: $ billion, 2015-19

Table 15: China pharmaceuticals market geography segmentation: $ billion, 2019

Table 16: China pharmaceuticals market share: % share, by value, 2019

Table 17: China pharmaceuticals market value forecast: $ billion, 2019-24

Table 18: China size of population (million), 2015-19

Table 19: China gdp (constant 2005 prices, $ billion), 2015-19

Table 20: China gdp (current prices, $ billion), 2015-19

Table 21: China inflation, 2015-19

Table 22: China consumer price index (absolute), 2015-19

Table 23: China exchange rate, 2015-19

Table 24: India pharmaceuticals market value: $ billion, 2015-19

Table 25: India pharmaceuticals market geography segmentation: $ billion, 2019

Table 26: India pharmaceuticals market share: % share, by value, 2019

Table 27: India pharmaceuticals market value forecast: $ billion, 2019-24

Table 28: India size of population (million), 2015-19

Table 29: India gdp (constant 2005 prices, $ billion), 2015-19

Table 30: India gdp (current prices, $ billion), 2015-19

Table 31: India inflation, 2015-19

Table 32: India consumer price index (absolute), 2015-19

Table 33: India exchange rate, 2015-19

Table 34: Russia pharmaceuticals market value: $ billion, 2015-19

Table 35: Russia pharmaceuticals market geography segmentation: $ billion, 2019

Table 36: Russia pharmaceuticals market share: % share, by value, 2019

Table 37: Russia pharmaceuticals market value forecast: $ billion, 2019-24

Table 38: Russia size of population (million), 2015-19

Table 39: Russia gdp (constant 2005 prices, $ billion), 2015-19

Table 40: Russia gdp (current prices, $ billion), 2015-19

Table 41: Russia inflation, 2015-19

Table 42: Russia consumer price index (absolute), 2015-19

Table 43: Russia exchange rate, 2015-19

Table 44: Sanofi SA: key facts

Table 45: Sanofi SA: Annual Financial Ratios

Table 46: Sanofi SA: Key Employees

Table 47: Sanofi SA: Key Employees Continued

Table 48: EMS Sigma Pharma: key facts

Table 49: EMS Sigma Pharma: Key Employees

Table 50: Ache Laboratorios Farmaceuticos SA: key facts

Table 51: Ache Laboratorios Farmaceuticos SA: Key Employees

Table 52: Yangtze River Pharmaceutical Group: key facts

Table 53: Yangtze River Pharmaceutical Group: Key Employees

Table 54: Shanghai Pharmaceutical Co Ltd: key facts

Table 55: Shanghai Pharmaceutical Co Ltd: Annual Financial Ratios

Table 56: Shanghai Pharmaceutical Co Ltd: Key Employees

Table 57: Guangzhou Pharmaceuticals Corp: key facts

Table 58: Guangzhou Pharmaceuticals Corp: Key Employees

Table 59: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: key facts

List of Figures

List of Figures

Figure 1: BRIC pharmaceuticals industry, revenue($bn), 2015-24

Figure 2: BRIC pharmaceuticals industry, revenue($bn), 2015-19

Figure 3: BRIC pharmaceuticals industry, revenue($bn), 2019-24

Figure 4: Brazil pharmaceuticals market value: $ billion, 2015-19

Figure 5: Brazil pharmaceuticals market geography segmentation: % share, by value, 2019

Figure 6: Brazil pharmaceuticals market share: % share, by value, 2019

Figure 7: Brazil pharmaceuticals market value forecast: $ billion, 2019-24

Figure 8: Forces driving competition in the pharmaceuticals market in Brazil, 2019

Figure 9: Drivers of buyer power in the pharmaceuticals market in Brazil, 2019

Figure 10: Drivers of supplier power in the pharmaceuticals market in Brazil, 2019

Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2019

Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2019

Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2019

Figure 14: China pharmaceuticals market value: $ billion, 2015-19

Figure 15: China pharmaceuticals market geography segmentation: % share, by value, 2019

Figure 16: China pharmaceuticals market share: % share, by value, 2019

Figure 17: China pharmaceuticals market value forecast: $ billion, 2019-24

Figure 18: Forces driving competition in the pharmaceuticals market in China, 2019

Figure 19: Drivers of buyer power in the pharmaceuticals market in China, 2019

Figure 20: Drivers of supplier power in the pharmaceuticals market in China, 2019

Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2019

Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2019

Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in China, 2019

Figure 24: India pharmaceuticals market value: $ billion, 2015-19

Figure 25: India pharmaceuticals market geography segmentation: % share, by value, 2019

Figure 26: India pharmaceuticals market share: % share, by value, 2019

Figure 27: India pharmaceuticals market value forecast: $ billion, 2019-24

Figure 28: Forces driving competition in the pharmaceuticals market in India, 2019

Figure 29: Drivers of buyer power in the pharmaceuticals market in India, 2019

Figure 30: Drivers of supplier power in the pharmaceuticals market in India, 2019

Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2019

Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2019

Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in India, 2019

Figure 34: Russia pharmaceuticals market value: $ billion, 2015-19

Figure 35: Russia pharmaceuticals market geography segmentation: % share, by value, 2019

Figure 36: Russia pharmaceuticals market share: % share, by value, 2019

Figure 37: Russia pharmaceuticals market value forecast: $ billion, 2019-24

Figure 38: Forces driving competition in the pharmaceuticals market in Russia, 2019

Figure 39: Drivers of buyer power in the pharmaceuticals market in Russia, 2019

Figure 40: Drivers of supplier power in the pharmaceuticals market in Russia, 2019

Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2019

Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2019

Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2019

    Pricing

Quick Buy
Add to basket Enquire before buying

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports